about
High-resolution structures ofThermus thermophilusenoyl-acyl carrier protein reductase in the apo form, in complex with NAD+and in complex with NAD+and triclosanDetermination of the Crystal Structure and Active Residues of FabV, the Enoyl-ACP Reductase from Xanthomonas oryzaeStructure of the Yersinia pestis FabV Enoyl-ACP Reductase and Its Interaction with Two 2-Pyridone InhibitorsCrystal structures and kinetic properties of enoyl-acyl carrier protein reductase I fromCandidatus Liberibacter asiaticusStructures of trans-2-enoyl-CoA reductases from Clostridium acetobutylicum and Treponema denticola: insights into the substrate specificity and the catalytic mechanismUsing modern tools to probe the structure-function relationship of fatty acid synthasesEvaluating the sensitivity of Mycobacterium tuberculosis to biotin deprivation using regulated gene expressionTriclosan resistance of Pseudomonas aeruginosa PAO1 is due to FabV, a triclosan-resistant enoyl-acyl carrier protein reductaseDynamics of Plasmodium falciparum enoyl-ACP reductase and implications on drug discovery.Profound perturbation induced by triclosan exposure in mouse gut microbiome: a less resilient microbial community with elevated antibiotic and metal resistomes.Challenges of antibacterial discoveryMicrobial community degradation of widely used quaternary ammonium disinfectantsStaphylococcus epidermidis isolated in 1965 are more susceptible to triclosan than current isolates.The impact of triclosan on the spread of antibiotic resistance in the environment.The MUT056399 inhibitor of FabI is a new antistaphylococcal compound.Analysis of Enoyl-Acyl Carrier Protein Reductase Structure and Interactions Yields an Efficient Virtual Screening Approach and Suggests a Potential Allosteric Site.Ralstonia solanacearum fatty acid composition is determined by interaction of two 3-ketoacyl-acyl carrier protein reductases encoded on separate replicons.A Substrate Mimic Allows High-Throughput Assay of the FabA Protein and Consequently the Identification of a Novel Inhibitor of Pseudomonas aeruginosa FabAThe Multiple DSF-family QS Signals are Synthesized from Carbohydrate and Branched-chain Amino Acids via the FAS Elongation CycleChronic exposure to triclosan sustains microbial community shifts and alters antibiotic resistance gene levels in anaerobic digesters.Aqueous Molecular Dynamics Simulations of the M. tuberculosis Enoyl-ACP Reductase-NADH System and Its Complex with a Substrate Mimic or Diphenyl Ethers Inhibitors.Crystallographic insights into the structure-activity relationships of diazaborine enoyl-ACP reductase inhibitors.The two functional enoyl-acyl carrier protein reductases of Enterococcus faecalis do not mediate triclosan resistanceTriclosan Resistome from Metagenome Reveals Diverse Enoyl Acyl Carrier Protein Reductases and Selective Enrichment of Triclosan Resistance Genes.Resistance to AFN-1252 arises from missense mutations in Staphylococcus aureus enoyl-acyl carrier protein reductase (FabI).Inefficient translation renders the Enterococcus faecalis fabK enoyl-acyl carrier protein reductase phenotypically crypticDiscrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay.The structural role of the carrier protein--active controller or passive carrier.Recent advances in inhibitors of bacterial fatty acid synthesis type II (FASII) system enzymes as potential antibacterial agents.Fatty acid biosynthesis revisited: structure elucidation and metabolic engineering.Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors as potential antituberculotics: development in the past decade.Crystallization and preliminary X-ray crystallographic studies of enoyl-acyl carrier protein reductase (FabI) from Psuedomonas aeruginosa.Recent Advances and Structural Features of Enoyl-ACP Reductase Inhibitors of Mycobacterium tuberculosis.Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase.Triclosan inhibition of mycobacterial InhA in Saccharomyces cerevisiae: yeast mitochondria as a novel platform for in vivo antimycolate assays.Functional Characterization of Triclosan-Resistant Enoyl-acyl-carrier Protein Reductase (FabV) in Pseudomonas aeruginosa.Genome of Ca. Pandoraea novymonadis, an Endosymbiotic Bacterium of the Trypanosomatid Novymonas esmeraldas.Unsaturated Fatty Acid Synthesis in the Gastric Pathogen Helicobacter pylori Proceeds via a Backtracking Mechanism.Rational questing for potential novel inhibitors of FabK from Streptococcus pneumoniae by combining FMO calculation, CoMFA 3D-QSAR modeling and virtual screening.Sensitivities of seven algal species to triclosan, fluoxetine and their mixtures
P2860
Q27673784-A0932F58-982F-4D24-B93D-3EA8A875092FQ27675305-D91508CB-F1E4-4128-8797-7B2A418FC58AQ27676726-36D839F4-6B37-4FD7-84DC-DA246CAB4825Q27681261-3B84F259-4C22-4235-AB1D-F7242E0709BCQ27682745-C0073298-E4C0-466A-9D65-D5809CDDBE78Q28080940-1BF90304-1E49-4C70-AAFF-FA33B6E902A2Q28477282-EABF9A43-30FB-4B78-A33D-5FBFF062BABDQ28492833-7810F4F1-E926-4193-82FE-BAC74C8C1262Q30421174-BBEFC8EC-E45A-46A4-BBB8-BA7402E2B96CQ33792232-40A721A7-76D0-4478-9DBE-6C25C84BDFE7Q33793074-119CE5DF-05A4-4B52-9854-3B9A8ABC35B3Q34261337-277D091A-63D0-4490-BC97-C946EE117D1FQ34685701-41F1002D-16D0-4EB6-902C-24DE0A44E928Q34969983-46D2D175-6A1E-4E55-A87C-11593430AD0BQ35270339-9E51BF15-3038-4CC1-9627-C5DFEC91B680Q35741705-18AB4733-EB81-418D-A821-3760BC37D886Q35816769-46B23583-A806-4386-9018-87B4A7D1C248Q35839906-8C4DB095-9807-401E-AD20-B1D872BE83FFQ35974214-8B85F6EF-00F3-40D9-A0A7-8BBB029DB0F7Q36049667-93055C9E-ADDC-4D09-800F-A1B6278745E8Q36247329-84BC5614-75F1-4BB2-A9FE-623CCBCE573CQ36337901-CB66017F-A00D-4AEE-B257-904ACDEF137FQ37218845-CB2EBD15-0F68-4C4B-9AB1-DE342D02CF97Q37220145-3EB24F5C-8C29-43C9-9369-F59C730B67F6Q37404976-E532BEAF-038E-4138-B3EF-948B02862E46Q37545596-535A7B25-47CA-44B8-BE90-C3866FF38E94Q37635732-AE5DEC98-42A2-4CCB-A1A7-ABF6A8530700Q38038812-1B26961C-1DCE-4933-AE2E-DFC1AD74784FQ38124842-52A14641-1D73-4880-9ABC-2E71DEB038D1Q38264138-1D47922A-F500-43C4-81A0-196D6ECFE55DQ38266496-447C3C26-9BEF-43B0-9206-AEC34F2ECDB4Q38477356-348684E8-8838-41E2-B1B9-72804B7119BFQ38989303-3C00BD8E-09D9-418C-B278-897112B7D8BCQ39812716-4F49048F-47E6-4A83-B16D-857FCB24F4A9Q41845049-5F134264-9A83-41A9-BD96-A4B6636B366EQ42362561-2DDD253E-FAA1-4359-8052-B929E17C7448Q42372731-BD2C0EF7-80FC-4E29-B9FF-1A5444658D9EQ47165474-00C591E2-8EF6-4C6C-833B-C711251B703DQ51658617-CA193A19-094B-42D6-B1AF-C9469F040F90Q58603142-278C8230-15CA-4C38-872E-5CE81B531B68
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diversity in enoyl-acyl carrier protein reductases.
@en
Diversity in enoyl-acyl carrier protein reductases.
@nl
type
label
Diversity in enoyl-acyl carrier protein reductases.
@en
Diversity in enoyl-acyl carrier protein reductases.
@nl
prefLabel
Diversity in enoyl-acyl carrier protein reductases.
@en
Diversity in enoyl-acyl carrier protein reductases.
@nl
P2860
P1476
Diversity in enoyl-acyl carrier protein reductases.
@en
P2093
J E Cronan
R P Massengo-Tiassé
P2860
P2888
P304
P356
10.1007/S00018-009-8704-7
P577
2009-05-01T00:00:00Z